GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Kimia Farma Tbk (GREY:PTKMF) » Definitions » EV-to-EBITDA

PT Kimia Farma Tbk (PT Kimia Farma Tbk) EV-to-EBITDA : -12.88 (As of Jun. 19, 2024)


View and export this data going back to 2015. Start your Free Trial

What is PT Kimia Farma Tbk EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, PT Kimia Farma Tbk's enterprise value is $1,014.46 Mil. PT Kimia Farma Tbk's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-78.78 Mil. Therefore, PT Kimia Farma Tbk's EV-to-EBITDA for today is -12.88.

The historical rank and industry rank for PT Kimia Farma Tbk's EV-to-EBITDA or its related term are showing as below:

PTKMF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -13.2   Med: 19.2   Max: 45.44
Current: -8.27

During the past 13 years, the highest EV-to-EBITDA of PT Kimia Farma Tbk was 45.44. The lowest was -13.20. And the median was 19.20.

PTKMF's EV-to-EBITDA is ranked worse than
100% of 82 companies
in the Medical Distribution industry
Industry Median: 9.93 vs PTKMF: -8.27

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-19), PT Kimia Farma Tbk's stock price is $0.00. PT Kimia Farma Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.000. Therefore, PT Kimia Farma Tbk's PE Ratio for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


PT Kimia Farma Tbk EV-to-EBITDA Historical Data

The historical data trend for PT Kimia Farma Tbk's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kimia Farma Tbk EV-to-EBITDA Chart

PT Kimia Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.01 36.87 16.99 19.80 -13.71

PT Kimia Farma Tbk Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.80 16.56 13.42 14.66 -13.71

Competitive Comparison of PT Kimia Farma Tbk's EV-to-EBITDA

For the Medical Distribution subindustry, PT Kimia Farma Tbk's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kimia Farma Tbk's EV-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Tbk's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where PT Kimia Farma Tbk's EV-to-EBITDA falls into.



PT Kimia Farma Tbk EV-to-EBITDA Calculation

PT Kimia Farma Tbk's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1014.459/-78.781
=-12.88

PT Kimia Farma Tbk's current Enterprise Value is $1,014.46 Mil.
PT Kimia Farma Tbk's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-78.78 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Kimia Farma Tbk  (GREY:PTKMF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

PT Kimia Farma Tbk's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.00/0.000
=N/A

PT Kimia Farma Tbk's share price for today is $0.00.
PT Kimia Farma Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


PT Kimia Farma Tbk EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of PT Kimia Farma Tbk's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Kimia Farma Tbk (PT Kimia Farma Tbk) Business Description

Traded in Other Exchanges
Address
Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in three categories including Ethical, Generic and others. Some of its product offerings include Topgesic, Protofen, Neurodial, Omeprazole, Antalgin, Pethidine, Salicylfresh and Doveri. It generates maximum revenue from the retail segment.

PT Kimia Farma Tbk (PT Kimia Farma Tbk) Headlines

No Headlines